MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.1200
0.00 (0.00%)
At close: Oct 20, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 873.97 thousand as of October 20, 2026. It is the 50,117th most valuable company in the world and the 2,524th biggest in Canada. Its market cap has decreased by 74.48% in one year.
Market Cap
873.97K
Enterprise Value
2.89M
Revenue
n/a
Global Rank
Country Rank
#2,524 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 873.97K, a decrease of -98.91%. That is a compound annual growth rate of -72.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 873.97K | -85.42% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 3.54M |
| Quest PharmaTech | 3.38M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.06M |
| Universal Ibogaine | 1.56M |
| Doseology Sciences | 801.16K |
| Vaxil Bio | 577.68K |
| Waverley Pharma | 540.00K |